ADVERTISEMENT
No Result
View All Result
English Edition
Contribute
Saturday, May 21st 2022
Today's Paper
The Kashmir Monitor
  • LatestLive
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Editorial
  • Business
  • Sports
  • Education
  • Health
  • Tech-Film
  • Auto
  • Crypto
  • Travel
  • Shopping
The Kashmir Monitor
  • LatestLive
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Editorial
  • Business
  • Sports
  • Education
  • Health
  • Tech-Film
  • Auto
  • Crypto
  • Travel
  • Shopping
The Kashmir Monitor
Home Health

Russia to supply Egypt with 25 million doses of coronavirus vaccine

Monitor News Desk by Monitor News Desk
Oct. 01, 2020 Updated 3:34 pm. IST
A A
A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia (Courtesy: Reuters)

A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia (Courtesy: Reuters)

0
SHARES
63
VIEWS
Share on FacebookShare on Twitter


 

The Russian Direct Investment Fund (RDIF) yesterday announced that it had agreed to supply Egypt with 25 million doses of its Sputnik-V coronavirus vaccine through Pharco, one of the leading pharmaceutical groups in Egypt, reports said on Thursday.

ADVERTISEMENT

RDIF, Russia’s national wealth fund, said in a statement that the agreement will support the Egyptian Ministry of Health’s efforts to provide 25 per cent of the Egyptian population with a vaccine against the coronavirus, adding that more vaccines will be distributed to neighbouring countries in the future.

Last week, RDIF said Russia received requests to export more than one billion doses of its Sputnik-V coronavirus vaccine to other countries.

In August, Russia became the first country in the world to register and start producing a vaccine against the coronavirus.

The World Health Organisation (WHO) has, however, not approved the vaccine since it has not completed phase 3 trials which are perceived as crucial to guarantee efficiency and safety.

ADVERTISEMENT

Next Post
Domicile controversy: J&K Bank puts CFO’s appointment ‘on hold’

Another J&K Bank scam: Mumbai housekeeping firm cleaned bank of Rs 6.29 crore

Discussion about this post


The Kashmir Monitor

Copyright © 1996 - 2022

Navigate Site

  • Donate
  • Status Page
  • Sitemap
  • Privacy Policy
  • DMCA Notice
  • About us

Follow Us

No Result
View All Result
  • Home Page
  • Latest News
  • Lead Stories
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Education
  • Business
  • Environment
  • Health
  • Sports
  • Editors’ Picks
  • Videos
  • Lifestyle
  • Tech-Film
  • Today’s Paper

Copyright © 1996 - 2022